勒梅特血管
LMAT
80.82
-2.34
-2.81%
勒梅特血管
US · LMAT
#2839 按市值排名
上市于 1970
80.82
-2.34
-2.81%
实时 - 追踪5344个代码 - 心跳于45秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了3家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 101.60% +0.07pp
- 机构数量
- 389 -3
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund91.61%
Individual/Insider6.84%
Hedge Fund4.89%
Public Company2.45%
Government Pension Fund1.19%
Private Company0.67%
Insurance Company0.31%
Family Office/Trust0.24%
Sovereign Wealth Fund0.17%
主要股东 截至 2026-06-30
BlackRock
14.31% · 3.27M 股
George LeMaitre
6.40% · 1.46M 股
Conestoga Capital Advisors, LLC
5.98% · 1.37M 股
Vanguard Capital Management, LLC
4.84% · 1.11M 股
First Trust Advisors L.P.
4.78% · 1.09M 股
Congress Asset Management Company, LLP
4.21% · 963.71K 股
State Street Global Advisors
3.94% · 901.42K 股
Copeland Capital Management, LLC
3.67% · 839.46K 股
Geode Capital Management, LLC
3.45% · 788.84K 股
T. Rowe Price Group, Inc.
3.30% · 755.14K 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 32次买入 · 18次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| George LeMaitre | Chairperson & CEO | 6.40% |
| John O'Connor | Independent Director | 0.27% |
| Joseph Pellegrino | CFO, Treasurer, Secretary & Director | 0.07% |
| David Roberts | President | 0.03% |
| John Roush | Independent Director | 0.03% |
| Trent Kamke | Officer | 0.02% |
| Lawrence Jasinski | Independent Director | 0.02% |
| Bridget Ross | Independent Director | 0.01% |
| Martha Shadan | Independent Director | 0.01% |
| Dorian LeBlanc | Chief Financial Officer | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-02 | George LeMaitre | Chairperson & CEO | Other Derivative Acquisition | +71 | -- |
| 2026-09-02 | David Roberts | President | Other Derivative Acquisition | +24 | -- |
| 2026-09-02 | Lawrence Jasinski | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-02 | John Roush | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-02 | John O'Connor | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-02 | Trent Kamke | Officer | Other Derivative Acquisition | +13 | -- |
| 2026-09-02 | Joseph Pellegrino | CFO, Treasurer, Secretary & Director | Other Derivative Acquisition | +22 | -- |
| 2026-09-02 | Martha Shadan | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-09-02 | Dorian LeBlanc | Chief Financial Officer | Other Derivative Acquisition | +6 | -- |
| 2026-08-31 | John Roush | Independent Director | Derivative Exercise and Retained | +3,444 | $48.60 |
| 2026-07-28 | Bridget Ross | Independent Director | Intent to Sell (Form 144) | -4,322 | $103.94 |
| 2026-06-03 | George LeMaitre | Chairperson & CEO | Other Acquisition | +11,974 | -- |
| 2026-06-03 | George LeMaitre | Chairperson & CEO | Other Disposition | -11,974 | -- |
| 2026-06-03 | George LeMaitre | Chairperson & CEO | Other Derivative Acquisition | +61 | -- |
| 2026-06-03 | David Roberts | President | Other Derivative Acquisition | +21 | -- |
| 2026-06-03 | Lawrence Jasinski | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-06-03 | John Roush | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-06-03 | John O'Connor | Independent Director | Other Derivative Acquisition | +4 | -- |
| 2026-06-03 | Trent Kamke | Officer | Other Derivative Acquisition | +11 | -- |
| 2026-06-03 | Joseph Pellegrino | CFO, Treasurer, Secretary & Director | Other Derivative Acquisition | +19 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
勒梅特血管 讨论区 0 条评论